References
- 1WHO.
A global brief on hypertension: Silent killer, global public health crisis (WHO/DCO/WHD/2013.2) . World Health Orgnization; 2013. DOI: 10.5005/ijopmr-24-1-2 - 2Costa SM, Lima CA, Nobre A, Vieira DMA, Leal, ALR. Hypertension bearers with high risk/big risk of cardiovascular diseases and socioeconomic and health indicators. Rev Assoc Med Bras (1992). 2018; 64(7): 601–10. DOI: 10.1590/1806-9282.64.07.601
- 3Ezzati M, Vander Hoorn S, Lawes CM, et al. Rethinking the “diseases of affluence” paradigm: Global patterns of nutritional risks in relation to economic development. PLoS Med. 2005; 2(5):
e133 . DOI: 10.1371/journal.pmed.0020133 - 4Li H, Kong F, Xu J, Zhang M, Wang A, Zhang Y. Hypertension subtypes and risk of cardiovascular diseases in a Mongolian population, inner Mongolia, China. Clin Exp Hypertens. 2016; 38(1): 39–44. DOI: 10.3109/10641963.2015.1060981
- 5Lu X, Huang J, Wang L, et al. Genetic predisposition to higher blood pressure increases risk of incident hypertension and cardiovascular diseases in Chinese. Hypertension. 2015; 66(4): 786–92. DOI: 10.1161/HYPERTENSIONAHA.115.05961
- 6Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. DOI: 10.3322/caac.21492
- 7Fidler MM, Soerjomataram I, Bray F. A global view on cancer incidence and national levels of the human development index. Int J Cancer. 2016; 139(11): 2436–46. DOI: 10.1002/ijc.30382
- 8Bui Van N, Pham Van Q, Vo Hoang L, et al. Prevalence and risk factors of hypertension in two communes in the Vietnam northern mountainous, 2017. Biomed Res Int. 2018; 2018:
7814195 . DOI: 10.1155/2018/7814195 - 9Wang Z, Wang X, Hao G, et al. A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012–2015. Int J Cardiol. 2019; 275: 165–70. DOI: 10.1016/j.ijcard.2018.10.047
- 10Krupa-Wojciechowska B, Zdrojewski T. Socio-economic factors in the management of hypertension: The Polish experience. J Hypertens. 2004; 22(3): 661–2. DOI: 10.1097/00004872-200403000-00031
- 11Zanchetti A. Role of socio-economic factors, blood pressure measurement, and therapeutic strategies in hypertension. J Hypertens. 2015; 33(2): 193–4. DOI: 10.1097/HJH.0000000000000487
- 12WHO. Noncommunicable diseases country profiles, 2018. 2018.
- 13Wang Y, Klaric L, Yu X, et al. The association between glycosylation of immunoglobulin G and hypertension: A multiple ethnic cross-sectional study. Medicine (Baltimore). 2016; 95(17):
e3379 . DOI: 10.1097/MD.0000000000003379 - 14WHO. Draft action plan for the prevention and control of non-communicable diseases 2013–2020. 2013.
- 15Laxmaiah A, Meshram, II, Arlappa N, et al. Socio-economic & demographic determinants of hypertension & knowledge, practices & risk behaviour of tribals in India. Indian J Med Res. 2015; 141(5): 697–708.
- 16Tompkins G, Forrest LF, Adams J. Socio-economic differences in the association between self-reported and clinically present diabetes and hypertension: Secondary analysis of a population-based cross-sectional study. PLoS One. 2015; 10(10):
e0139928 . DOI: 10.1371/journal.pone.0139928 - 17Khazaei S, Rezaeian S, Khazaei S, Mansori K, Sanjari Moghaddam A, Ayubi E. Effects of human development index and its components on colorectal cancer incidence and mortality: A global ecological study. Asian Pac J Cancer Prev. 2016; 17(S3): 253–6. DOI: 10.7314/APJCP.2016.17.S3.253
- 18Programme. UND. Human development report 2015. 2015.